Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BNTX BioNTech > Detailed Quotes

BNTX BioNTech

130.220
+2.570+2.01%
Trading Session 09/27 13:06 ET
High
133.410
Open
128.000
Turnover
63.72M
Low
128.000
Pre Close
127.650
Volume
486.78K
Market Cap
31.60B
P/E(TTM)
2.61
52wk High
369.680
Shares
242.69M
P/E(Static)
2.95
52wk Low
117.080
Float Cap
11.25B
Bid/Ask %
0.00%
Historical High
457.931
Shs Float
86.43M
Volume Ratio
0.81
Historical Low
12.361
Dividend TTM
--
Div Yield TTM
--
P/B
1.86
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.56%
Amplitude
4.24%
Avg Price
130.895
Lot Size
1
Float Cap
11.25B
Bid/Ask %
0.00%
Historical High
457.931
Shs Float
86.43M
Volume Ratio
0.81
Historical Low
12.361
Dividend TTM
--
P/B
1.86
Dividend LFY
--
Turnover Ratio
0.56%
Amplitude
4.24%
Avg Price
130.895
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
BioNTech SE engages in the development of novel medicines at the intersection of immunology and synthetic biology. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Ozlem Tureci and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
CEO: Professor Ugur Sahin, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...